← BACK TO HOMEPAGE ← BACK TO PATREON
MRAM // NASDAQ // MAGNETORESISTIVE MEMORY (MRAM)
THEVALUETRADER RESEARCH
DEEP DIVE · AUG 2026
REF · Q2 FY26 10-Q REVIEW

Everspin Technologies, Inc.

Chandler, Arizona · Everspin describes itself as a leading supplier of discrete MRAM memory [3]
Price · Aug 21, 2026 · approx. $17.98, intraday snapshot supplied in the source report
~$17.98
▼ 65.1% off 52-week high ($51.50)
52-WEEK RANGE $5.86 – $51.50 · YTD +93.8%
Everspin's core product sales are accelerating, but the investment case still depends on converting a costly manufacturing buildout and new product roadmap into durable GAAP earnings.
MARKET CAP~$437.8M
TTM REVENUE$62.471M
CASH (6/30/26)$43.896M, no meaningful debt
GROSS MARGIN52.7–53.9% (Q1–Q2 FY26)
TRAILING P/S~7.0x
ANALYST COVERAGECraig-Hallum · Jones Trading · Needham [10]

Market cap, TTM revenue and P/S are TheValueTrader calculations, not company-reported figures. Shares outstanding stood at 24,350,009 on Jul 30, 2026 [1]. TTM revenue = FY2025 revenue + H1 2026 − H1 2025 = $55.202M + $33.608M − $26.339M = $62.471M [1][4].

φ 01
What Does Everspin Sell?

Everspin (Chandler, Arizona; 85 employees as of Dec 31, 2025 [3]) designs and sells MRAM, a non-volatile memory storing data as a magnetic state rather than an electrical charge. It reads and writes closer to DRAM/SRAM speeds than flash and holds data without external power. Retention, temperature range and write-cycle tolerance are product-specific, not universal claims; for UNISYST, the company targets at least ten years of retention at extreme temperatures [7]. That fits industrial, energy, data-center and aerospace/defense uses, where reliability outweighs raw density.

The company holds 596 issued patents and 141 pending as of Dec 31, 2025 [3]. PERSYST covers the established Toggle- and STT-MRAM lines and is the current revenue base. UNISYST, unveiled March 2026, is a planned higher-density code-and-data platform for a broader market than PERSYST serves today [7].

φ 02
What Has Improved Financially?

Growth picked up after flat years. FY2025 revenue was $55.202M, up 9.5% [4]. Q1 2026 came in at $14.872M, and Q2 2026 hit a record $18.736M, up 41.9% year over year [1][2]. The gain was broad-based. Product revenue rose 38.1% to $15.313M and other revenue rose 62.2% to $3.423M, partly from first billings under the new defense subcontract [1][2]. Q2 gross margin was 53.9% on a GAAP basis [1]. Management guides Q3 2026 to $19.5M–$20.5M revenue and $0.10–$0.15 non-GAAP EPS, a target rather than a reported result [2].

Revenue Growth and Mix
$ MILLIONS · PRODUCT VS. OTHER REVENUE, BY QUARTER
$13.2M Q2'25 P $11.1 · O $2.1 $14.9M Q1'26 P $14.1 · O $0.8 $18.7M Q2'26 P $15.3 · O $3.4 $20.0M mid Q3'26E $19.5–20.5 range
Product revenue
Other (licensing, royalties, engineering)
Q3 2026 guidance (not yet reported)
Why it matters both revenue lines grew, not just one. Q3 guidance implies another step-up at the midpoint, but it is a target, not a result [1][2].
φ 03
How Solid Is the Profitability?
GAAP versus non-GAAP profits

Q2 2026 GAAP net loss came to $3.589M (-$0.15/share), while non-GAAP net income was $2.862M (+$0.11/share) [1]. The $6.451M bridge between the two consists of $1.374M in stock compensation, $4.027M in litigation costs and $1.050M in one-time Microchip engineering costs [1]. The math is correct, and most of it is litigation and foundry related rather than routine. Everspin is profitable on a non-GAAP basis but has not shown sustained GAAP profitability, and non-GAAP is not a substitute for it.

Why GAAP and Non-GAAP Tell Different Stories
$ MILLIONS · Q2 2026 BRIDGE FROM GAAP NET LOSS TO NON-GAAP NET INCOME
0 -$3.589M +$1.374M +$4.027M +$1.050M +$2.862M GAAP net loss + Stock comp + Litigation + Microchip NRE Non-GAAP income
GAAP loss
Excluded add-back
Non-GAAP income
Why it matters most of the bridge is litigation and foundry related rather than routine. The result is real, but it is not proven GAAP profitability [1].
Cash, investment and dilution

Operating cash flow slowed to $0.729M in H1 2026 from $6.455M in H1 2025, while capex/intangibles spending rose to $6.653M from $3.878M, funding the foundry buildout [1]. Option and ESPP proceeds covered much of the gap (below) [1]. The balance sheet is liquid with no meaningful debt, but the buildout is capital-intensive and partly equity-funded.

Cash Generation, Investment and Equity Proceeds
$ MILLIONS · H1 2025 VS. H1 2026
$6.455M $0.729M Operating cash flow $3.878M $6.653M Capex + intangibles $0.322M $5.403M Option/ESPP proceeds
H1 2025
H1 2026
SHARES22.978M → 24.271M (+5.6%)
CASH$44.450M → $43.896M
Why it matters cash held broadly stable despite heavier investment, but operating cash flow weakened and equity proceeds rose, a mix worth watching [1][4].
φ 04
Opportunities in Defense, Microchip and New Products
φ 05
What Must Happen Next
1 · Q3 Revenue≥ $19.5–20.5M guide
2 · UNISYSTSamples & qualification on track
3 · Microchip RampOn schedule, no cost overrun
4 · Cash FlowOperating CF and share count stabilize
5 · USITC CaseTarget date Jul 6, 2027

Everspin now has stronger product growth and credible strategic opportunities, but the shares still require investors to underwrite manufacturing execution, customer concentration, legal uncertainty, and a meaningful gap between GAAP and adjusted earnings.

φ 06
Sources
  1. 01Q2 2026 10-Q
  2. 02Q2 2026 earnings release
  3. 03FY2025 10-K
  4. 04FY2025 earnings release
  5. 05Microchip 8-K
  6. 06Amentum subcontract, Ex. 10.2
  7. 07UNISYST launch
  8. 08PERSYST 256Mb roadmap
  9. 09Investor presentation (TAM, FY29 target)
  10. 10Analyst coverage list
  11. 11MaxLinear MOU

Bracketed numbers = facts from the item above. "Target," "guidance" or "management-estimated" = Everspin's own forward-looking statements. "Our calculation" = derived by TheValueTrader from cited numbers.